Pharmacists are stepping into a critical role in addiction treatment, expanding access to life-saving medications like buprenorphine through pharmacy-based MOUD clinics. This episode examines how this innovative model is transforming care for patients with opioid use disorder and what pharmacists need to understand before considering an expansion of services in this space. Tune in to learn how pharmacist-led addiction treatment can improve patient outcomes, strengthen communities, and help combat the opioid crisis.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Korey Kreider, PharmD
Pharmacist, Owner
Medicine Man


CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:

• If you are already enrolled in this course, click here to redeem your credit. 
• To purchase this episode and claim your CPE credit, click here. 

CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Explain the role of pharmacists in providing medication for opioid use disorder (MOUD) and the impact of pharmacy-based addiction treatment services.
2. Identify key regulatory and scope of practice considerations pharmacists must evaluate before expanding services to include addiction treatment.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-190-H01-P
Initial release date: 5/19/2025
Expiration date: 5/19/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram